Navigation Links
Trick-or-Treat Your Way to an Allergy-Free Halloween
Date:10/18/2007

AAAAI urges children to recognize symptoms and carry epinephrine

MILWAUKEE, Oct. 18 /PRNewswire/ -- Halloween is right around the corner and millions of children are preparing to sport their ghost and vampire costumes for school parties and a night of trick-or-treating. However, for children who suffer from severe food allergies, Halloween is a time where extra precaution must be taken.

The American Academy of Allergy, Asthma and Immunology (AAAAI) asks children and parents to watch out for hidden foods that could trigger a life threatening allergic reaction called anaphylaxis. Food-related anaphylaxis leads to 150-200 deaths each year, so every exposure should be taken seriously.

Peanuts, tree nuts, eggs, milk and soy are the most common causes of food allergies in children. Eating even a small amount of these foods could trigger anaphylaxis.

Symptoms of anaphylaxis include severe headache, nausea and vomiting, sneezing and coughing, hives, swelling of the lips, tongue and throat, and itching all over the body. The most dangerous symptoms include difficulty breathing, a drop in blood pressure, and shock -- all of which can be fatal.

If any of these symptoms occur, give the child self-injectable epinephrine, call 911 immediately, and schedule a follow-up appointment with your allergist/immunologist.

Here are some helpful Halloween tips to avoid hidden food dangers:

-- When classroom parties are planned, parents can help by packing treats

from home that their food-allergic child can eat.

-- Create a "candy swap" with siblings or friends so that

allergen-containing candies can be traded for other treats such as

stickers or toys.

-- Take the focus off of trick-or-treating by hosting a costume party that

emphasizes fun instead of candy. Halloween stickers, pencils, spider

rings and stamps are great alternatives for goody bags.

-- Provide neighbors with alle
'/>"/>

SOURCE The American Academy of Allergy, Asthma and Immunology
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2


Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...e of risks, many hesitate to take breast cancer dr...thDay News) -- Worries about side effects are a ma... high risk for breast cancer are willing to take t...udy finds. , In an effort to inform women about...at the University of Michigan Comprehensive Cancer...
(Date:12/4/2009)...JACKSONVILLE, Fla., Dec. 4 Today, ...for their work in improving the health of Florida,... for a Healthy Florida,s 2009 Sapphire Award cerem...atewide award that recognizes and promotes organiz...sing health disparities within their communities. ...
(Date:12/4/2009)...S, N.J., Dec. 4 Movado G...amp; Co. Jewelers, Atlanta, Georgia, shared in a t...pen quarterfinalist Melanie Oudin for her stellar ...youngest American quarterfinalist at the Open sinc...i-bin/prnh/20091204/NY21184 ) ,, At a celebrato...
(Date:12/4/2009)...GTON, Dec. 4 The follow...he Heinz Family Philanthropies: ,, Credit Senat... a significant contribution to the health care deb...ericans living with Phenylketonuria (PKU) control ... others living with serious chronic conditions are...
(Date:12/4/2009)...ile usually conveys true personality, study finds ...oes your profile on an online social network, such...od that it does, reports a new study, which finds ...ead of idealized identities. , "I was surprise...on is that people are using their profiles to prom...
Breaking Medicine News(10 mins):Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Top Nonprofits Honored for Improving Health of Floridians 2Health News:Top Nonprofits Honored for Improving Health of Floridians 3Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Online Identities Likely to Match Reality 2
...y shows infusing heart attack patients with high d...ase damage.// Researchers from the Cleveland ...d version of HDL, or good cholesterol, which natur...saline. Researchers say they got the idea for...
...s for premature birth are a mystery in nearly half...maternal or fetal stress, infections, high blood p...ut in the rest, the reason is unknown , experts sa...blic health concern because underdeveloped babies ...
...s for premature birth are a mystery in nearly half...maternal or fetal stress,// infections, high blood...ut in the rest, the reason is unknown , experts sa...ublic health concern because underdeveloped babies...
...tudies have shown inhaled corticosteroids can decr...earchers now say long-term use of ICS therapy is n... Corticosteroids are commonly used to treat as...ion in the airways of the lungs. They also make ot...
... creating a whole new experience for patients in d...sers are putting more smiles on their patients' fa...lly invasive, result in less tissue removal, less ...ructure to treat disease. Some are even used to wh...
... doctors thought of rickets as a disease of the pa...ed a problem and prevention should start before bi...be given vitamin D supplementation.// Rickets i... to occur during rapid growth, when the body deman...
Other Medicine News:Health News:Women who conceive after a year have a higher chance of giving birth prematurely 2Health News:Women who conceive after a year have a higher chance of giving birth prematurely 2
(Date:12/4/2009)..., , BETHESDA, Md., Dec. 4 Dr...lts for prostate-specific antigen (PSA) recurrence...nts of biochemical recurrence rate in a Phase III ... for injection) or monthly leuprolide in prostate .... Prostate cancer patients who received FIRMAGON ...
(Date:12/3/2009)..., , NEW YORK, Dec. 3 Guid...rm, today announced the launch of their Sleep Apne...t monitors and projects trends and market share in...p Apnea Tracker captures actual patient usage for ...nited States from 15 different equipment providers...
(Date:12/3/2009)..., , SUNNYVALE, Calif., Dec. 3 /PRNewswire-..., a biopharmaceutical company focused on developin...ugs for the treatment of immune mediated diseases ...bcast and conference call on, Tuesday, December 8,...e and 8:00am Pacific Time) to discuss clinical dat...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Pearson Announces Leah Jewell as President of Health Science and Careers Division 55714 1Pearson Announces Leah Jewell as President of Health Science and Careers Division 55714 2Pearson Announces Leah Jewell as President of Health Science and Careers Division 55714 3ReBuilder Medical Technologies Inc s Dr Phillips to Speak to Ohio Investment Group 55711 1ReBuilder Medical Technologies Inc s Dr Phillips to Speak to Ohio Investment Group 55711 2CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 1CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 2CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 3
...AS, April 4, 2008 Data from five studies sponsore...d at the National Kidney,Foundation (NKF) 2008 Spr...e utilization studies involve PROCRIT(R) (Epoetin ...g utilization patterns and,costs of PROCRIT (EPO) ...s,related to chronic kidney disease (CKD) patients...
...iously-Stated Guidance Remains Unchanged, PRINCET...EDX ) today issued the following statement in resp... discontinuing its Phase 3 clinical,trial of front...LA-4,antibody (tremelimumab) compared to chemother...ey M. Nichol, M.B.Ch.B., Senior Vice President, Pr...
Other Medicine Technology:Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 2Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 3Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 4Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 5Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 6Medarex Announces Ipilimumab Program Continues to Move Forward 2Medarex Announces Ipilimumab Program Continues to Move Forward 3Medarex Announces Ipilimumab Program Continues to Move Forward 4Medarex Announces Ipilimumab Program Continues to Move Forward 5
HOME MULTI-DRUG TEST
SEDIPLAST ESR SYSTEM (with diluent)
SEDIPLAST ESR SYSTEM (without diluent)
Hemaprompt FG Gastric and Fecal Occult Blood Test
Medicine Products: